Ciclesonide inhibits TNFα- and IL-1β-induced monocyte chemotactic protein-1 (MCP-1/CCL2) secretion from human airway smooth muscle cells

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 302, Issue 8, 2012, Pages

  Patel, Jamie K ^a   Clifford, Rachel L ^a   Deacon, Karl ^a   Knox, Alan J ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Glucocorticoid; Inflammation; Nuclear factor B

Indexed keywords

CICLESONIDE; FORMOTEROL FUMARATE; I KAPPA B; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LUCIFERASE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

AIRWAY SMOOTH MUSCLE CELL; ARTICLE; BREATHING MUSCLE; CONSENSUS SEQUENCE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; DRUG MECHANISM; ENHANCER REGION; GENE ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; SMOOTH MUSCLE FIBER; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

ANTI-ALLERGIC AGENTS; BRONCHODILATOR AGENTS; CELL LINE; CHEMOKINE CCL2; ETHANOLAMINES; HUMANS; I-KAPPA B PROTEINS; INTERLEUKIN-1BETA; LUNG; MUSCLE, SMOOTH; PREGNENEDIONES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84859778814     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00257.2011     Document Type: Article

References (31)

1. Amrani Y, Lazaar AL, Panettieri RA Jr. Up-regulation of ICAM-1 by cytokines in human tracheal smooth muscle cells involves an NF-kB-dependent signaling pathway that is only partially sensitive to dexamethasone. J Immunol 163: 2128-2134, 1999.
2. Beck IM, Vanden Berghe W, Vermeulen L, Bougarne N, Vander Cruyssen B, Haegeman G, De Bosscher K. Altered subcellular distribution of MSK1 induced by glucocorticoids contributes to NF-kB inhibition. EMBO J 27: 1682-1693, 2008.
3. Bonello GB, Pham MH, Begum K, Sigala J, Sataranatarajan K, Mummidi S. An evolutionarily conserved TNF-α-responsive enhancer in the far upstream region of human CCL2 locus influences its gene expression. J Immunol 186: 7025-7038, 2011.
4. Chan CK, Kuo ML, Yeh KW, Ou LS, Chen LC, Yao TC, Huang JL. Sequential evaluation of serum monocyte chemotactic protein 1 among asymptomatic state and acute exacerbation and remission of asthma in children. J Asthma 46: 225-228, 2009.
5. Clayton AL, Mahadevan LC. MAP kinase-mediated phosphoacetylation of histone H3 and inducible gene regulation. FEBS Lett 546: 51-58, 2003.
6. Clifford RL, Coward WR, Knox AJ, John AE. Transcriptional regulation of inflammatory genes associated with severe asthma. Curr Pharm Des 17: 653-666, 2011.
7. Cooper JA Jr, Fuller JM, McMinn KM, Culbreth RR. Modulation of monocyte chemotactic protein-1 production by hyperoxia: importance of RNA stability in control of cytokine production. Am J Respir Cell Mol Biol 18: 521-525, 1998.
8. Dhawan L, Liu B, Blaxall BC, Taubman MB. A novel role for the glucocorticoid receptor in the regulation of monocyte chemoattractant protein-1 mRNA stability. J Biol Chem 282: 10146-10152, 2007.
9. Dunnill MS, Massarella GR, Anderson JA. A comparison of the quantitative anatomy of the bronchi in normal subjects, in status asthmaticus, in chronic bronchitis, and in emphysema. Thorax 24: 176-179, 1969.
10. Gonzalo JA, Lloyd CM, Wen D, Albar JP, Wells TN, Proudfoot A, Martinez AC, Dorf M, Bjerke T, Coyle AJ, Gutierrez-Ramos JC. The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness. J Exp Med 188: 157-167, 1998.
11. Gossye V, Elewaut D, Bougarne N, Bracke D, Van Calenbergh S, Haegeman G, De Bosscher K. Differential mechanism of NF-kB inhibition by two glucocorticoid receptor modulators in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 60: 3241-3250, 2009.
12. Holgate ST, Bodey KS, Janezic A, Frew AJ, Kaplan AP, Teran LM. Release of RANTES, MIP-1, and MCP-1 into asthmatic airways following endobronchial allergen challenge. Am J Respir Crit Care Med 156: 1377-1383, 1997.
13. Jahnz-Rozyk KM, Kuna P, Pirozynska E. Monocyte chemotactic and activating factor/monocyte chemoattractant protein (MCAF/MCP-1) in bronchoalveolar lavage fluid from patients with atopic asthma and chronic bronchitis. J Investig Allergol Clin Immunol 7: 254-259, 1997.
14. Kaur M, Holden NS, Wilson SM, Sukkar MB, Chung KF, Barnes PJ, Newton R, Giembycz MA. Effect of 2-adrenoceptor agonists and other cAMP-elevating agents on inflammatory gene expression in human ASM cells: a role for protein kinase A. Am J Physiol Lung Cell Mol Physiol 295: L505-L514, 2008.
15. Kazi AS, Lotfi S, Goncharova EA, Tliba O, Amrani Y, Krymskaya VP, Lazaar AL. Vascular endothelial growth factor-induced secretion of fibronectin is ERK dependent. Am J Physiol Lung Cell Mol Physiol 286: L539-L545, 2004.
16. Nie M, Corbett L, Knox AJ, Pang L. Differential regulation of chemokine expression by peroxisome proliferator-activated receptoragonists: interactions with glucocorticoids and 2-agonists. J Biol Chem 280: 2550-2561, 2005.
17. Ogawa A, Firth AL, Yao W, Rubin LJ, Yuan JX. Prednisolone inhibits PDGF-induced nuclear translocation of NF-kB in human pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 295: L648-L657, 2008.
18. Page SH, Wright EK Jr, Gama L, Clements JE. Regulation of CCL2 expression by an upstream TALE homeodomain protein-binding site that synergizes with the site created by the A-2578G SNP. PLos One 6: e22052, 2011.
19. Pang L, Knox AJ. Effect of IL-1, TNF, and IFN on induction of COX-2 in cultured human ASM cells. Br J Pharmacol 121: 579-587, 1997.
20. Park SK, Yang WS, Han NJ, Lee SK, Ahn H, Lee IK, Park JY, Lee KU, Lee JD. Dexamethasone regulates AP-1 to repress TNF-α induced MCP-1 production in human glomerular endothelial cells. Nephrol Dial Transplant 19: 312-319, 2004.
21. Postma DS, O'Byrne PM, Pedersen S. Comparison of the effect of low-dose ciclesonide and fixed-dose fluticasone propionate and salmeterol combination on long-term asthma control. Chest 139: 311-318, 2011.
22. Pype JL, Dupont LJ, Menten P, Van Coillie E, Opdenakker G, Van Damme J, Chung KF, Demedts MG, Verleden GM. Expression of monocyte chemotactic protein (MCP)-1, MCP-2, and MCP-3 by human airway smooth-muscle cells. Modulation by corticosteroids and T-helper 2 cytokines. Am J Respir Cell Mol Biol 21: 528-536, 1999.
23. Ramudo L, Yubero S, Manso MA, Vicente S, De Dios I. Signal transduction of MCP-1 expression induced by pancreatitis-associated ascitic fluid in pancreatic acinar cells. J Cell Mol Med 13: 1314-1320, 2009.
24. 276 phosphorylation of NF-kB p65 by MSK1 controls SCF expression in inflammation. PLos One 4: e4393, 2009.
25. Sousa AR, Lane SJ, Nakhosteen JA, Yoshimura T, Lee TH, Poston RN. Increased expression of the monocyte chemoattractant protein-1 in bronchial tissue from asthmatic subjects. Am J Respir Cell Mol Biol 10: 142-147, 1994.
26. Sutcliffe AM, Clarke DL, Bradbury DA, Corbett LM, Patel JA, Knox AJ. Transcriptional regulation of monocyte chemotactic protein-1 release by endothelin-1 in human airway smooth muscle cells involves NF-kB and AP-1. Br J Pharmacol 157: 436-450, 2009.
27. Szalai C, Kozma GT, Nagy A, Bojszko A, Krikovszky D, Szabo T, Falus A. Polymorphism in the gene regulatory region of MCP-1 is associated with asthma susceptibility and severity. J Allergy Clin Immunol 108: 375-381, 2001.
28. Teferedegne B, Green MR, Guo Z, Boss JM. Mechanism of action of a distal NF-kB-dependent enhancer. Mol Cell Biol 26: 5759-5770, 2006.
29. Watson ML, Grix SP, Jordan NJ, Place GA, Dodd S, Leithead J, Poll CT, Yoshimura T, Westwick J. Interleukin 8 and monocyte chemoattractant protein 1 production by cultured human airway smooth muscle cells. Cytokine 10: 346-352, 1998.
30. Wuyts WA, Vanaudenaerde BM, Dupont LJ, Demedts MG, Verleden GM. Involvement of p38 MAPK, JNK, p42/p44 ERK and NF-kB in IL-1 -induced chemokine release in human airway smooth muscle cells. Respir Med 97: 811-817, 2003.
31. Wuyts WA, Vanaudenaerde BM, Dupont LJ, Demedts MG, Verleden GM. Modulation by cAMP of IL-1 -induced eotaxin and MCP-1 expression and release in human airway smooth muscle cells. Eur Respir J 22: 220-226, 2003.